Mounjaro's half-life, in plain words

What the Mounjaro half-life means

Half-life is the time it takes for the amount of a medicine in your body to fall by half. For tirzepatide, the medicine in Mounjaro, the US label gives an elimination half-life of about 5 days and says this is what enables once-weekly dosing.¹

The reason is built into the molecule. Tirzepatide carries a fatty-acid chain that binds it to albumin, a protein in the blood, and the label says this prolongs its half-life; about 99% of it circulates bound to albumin.¹ The result is a once-weekly injection, given at any time of day, with or without meals.¹

A half-life is an average from studies, not a measurement of you. It says nothing about how well the medicine is working for you, and it isn't an instruction about when to inject.

Zepbound half-life vs Mounjaro

Same medicine, same maker, same once-weekly injection. The Zepbound label gives a half-life of about 5 to 6 days in people with overweight or obesity, and in people with obstructive sleep apnea and obesity; its overdosage section uses about 5 days.²

In the UK and EU there is no Zepbound: tirzepatide for weight management is sold as Mounjaro, which the MHRA authorized for that use in November 2023.⁵ Compare the two US brands in Mounjaro vs Zepbound.

Tirzepatide levels at a glance: what the labels say

The pharmacokinetic facts from the two US labels, in one place. They describe how the medicine behaves on average; none of them is an instruction.

From sections 12.1 to 12.3 of each label.^1,2 Where to inject is covered in Mounjaro injection sites.

How tirzepatide levels rise and settle

What the labels describe, step by step. It is how the medicine behaves on average, not a plan for any dose.

1. 8 to 72 hours
   The peak

   After an injection under the skin, tirzepatide reaches its highest level within 8 to 72 hours; Zepbound's label gives a median of about a day.^1,2

2. Through the week
   A slow fall

   With a half-life of about 5 days, the level comes down gradually over the rest of the week.¹

3. Weeks 1 to 4
   Building up

   Because the half-life is close to the week between doses, some of each dose is still there when the next one arrives, so levels build over the first weeks.

4. From week 4
   Steady state

   The labels say steady levels are reached after 4 weeks of once-weekly injections: from then on, while the dose stays the same, each week's rise and fall follows much the same pattern.^1,2

Figures from the Mounjaro and Zepbound prescribing information.^1,2 Handle's Between doses, a Premium feature in the iPhone app, draws an estimate from your own recorded doses instead of this general picture.

How long does Mounjaro stay in your system?

The honest answer: the US labels don't give a number. They give the half-life, the time to peak and the time to steady state, but no time for tirzepatide to clear after the last injection.^1,2

That sets tirzepatide apart from semaglutide, the medicine in Ozempic and Wegovy, whose labels do say how long it stays in the circulation after the last dose.^6,7 See Ozempic half-life. If you see a figure for tirzepatide elsewhere, check whether it comes from a label or is a calculation from the half-life. A calculation from an average can't tell you about your own body.

The UK regulator does give tirzepatide a time frame, but for pregnancy planning; see below.³

Mounjaro half-life vs Ozempic and other GLP-1 medicines

Label half-lives side by side. A half-life says how long a medicine lasts in the body, not how well it works, so these figures don't rank the medicines.

From each medicine's US prescribing information. More on semaglutide in Ozempic half-life, on whether there is a Mounjaro pill, and on the head-to-head trial of the two weekly injections in semaglutide vs tirzepatide.

Pregnancy plans and surgery: what the guidance says

In both situations below, the timing is a clinical decision. Here is what the labels and the UK regulator say, so you can raise it early.

If you're planning a pregnancy

UK guidance from the MHRA says GLP-1 medicines should not be taken during pregnancy or just before trying to get pregnant, and advises contraception while taking them and for a "wash-out" period afterwards. It lists that period as at least 1 month for tirzepatide (Mounjaro) and at least 2 months for semaglutide.³

In the US, the Zepbound label says weight loss is not recommended during pregnancy and advises stopping Zepbound once a pregnancy is recognized.² Both tirzepatide labels also say the medicine may make the contraceptive pill less effective, and advise a non-oral method, or an added barrier method, for 4 weeks after starting and after each dose increase.^1,2

If a pregnancy is possible or planned, tell your prescriber early; if you think you might already be pregnant, the MHRA says to speak to a healthcare professional straight away.³ The timing is something to plan with them, not to work out from a half-life.

If you have surgery or a procedure coming up

Tirzepatide slows stomach emptying, and the US labels report rare cases of pulmonary aspiration (stomach contents entering the lungs) in people on GLP-1 medicines under general anesthesia or deep sedation, despite fasting as instructed. They say there isn't enough data to know whether changing fasting instructions or temporarily stopping the medicine would lower that risk, and ask you to tell your healthcare providers before any planned surgery or procedure.^1,2

In the UK, the MHRA asks anaesthetists to make an individualised assessment of the risk, and advises patients not to stop treatment without first discussing it with their doctor.⁴ So tell your surgeon and anesthesiologist (anaesthetist in the UK) that you take Mounjaro, and let them decide what, if anything, changes.

Questions to bring to your prescriber or pharmacist

The half-life explains the weekly rhythm. These questions cover the decisions it can't make.

1. What should I do if I'm late with a dose or miss one? (Mounjaro's instructions have a specific rule; ask rather than guess.)
2. I'm planning a pregnancy, or might become pregnant: when should we talk about stopping, and which contraception suits me until then?
3. I have surgery or a procedure coming up: who needs to know, and will anything change?
4. Could Mounjaro affect how my other medicines work, such as the contraceptive pill?
5. If my dose or medicine changes, what should I watch for and record in the weeks after?

Getting ready for an appointment? See preparing for a GLP-1 doctor appointment. For what the labels report about side effects, see Mounjaro side effects.